This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Clears MSN Labs Abiraterone Acetate 1000 mg, Mandates Phase IV TrialCDSCO Panel Clears MSN Labs' Abiraterone Acetate 1000 mg, Mandates Phase IV Trial
Dr Reddys Foils Email Spoofing Scam, Rs 2.16 Cr Recovered by Bengaluru PoliceCybercriminals Trick Dr Reddy's Finance Team, Divert Rs 2.16 Crore Payment
Cohance Lifesciences appoints Rahul Pradhan as VP - Operations to head API Unit III, AnkleshwarCohance Lifesciences appoints Rahul Pradhan as VP - Operations to head API Unit III, Ankleshwar
Cough Syrup Row: Rajasthan Practitioners Shift to Levocloperastine, Ambroxol Amid Dextromethorphan ConcernsDEG impurity above limit found in another cough syrup, Haryana issues alert
Dr Sujiv Nair takes over as Chief People Officer of MSN GroupDr Sujiv Nair takes over as Chief People Officer of MSN Group
Intas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing FinanceIntas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing Finance
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA concludes inspection at Marksans Pharma Goa facility with zero Form 483 observation
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck inks pact with Dr Falk Pharma for certain development, commercialization rights to MK 8690
Biopharma SHAKTI Gets Industry Backing as Budget 2026 Pushes India’s ₹10,000 Crore Biopharma AmbitionBiocon gets 2 USFDA observations for Visakhapatnam facility
Mankind Pharma revenue up by 11.5%; adj. EBITDA margin 25.9% in Q3FY26.Mankind Pharma net profit declines 21 percent to Rs 520 crore in Q2
Drug, Vaccine Lab Tests May Cost Up to Rs 45,000 with 5% Annual HikeHealth Ministry Revises BA/BE Study Rules: Minimum Sample Size Set at 18
JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLCJnJ bags USFDA approval for Caplyta for major depressive disorder
X